http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2390676-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa45a4e7fa25bf21eba8ee4db301e4a |
| publicationDate | 2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2390676-T3 |
| titleOfInvention | Method for the treatment of intraocular neovascular diseases |
| abstract | VEGF antagonist for use in a method of treating intraocular neovascular diseases in a human by intravitreal administration, the method comprising: a) administering the first three individual doses of the VEGF antagonist at one month intervals; followed by b) administering six second individual doses of the antagonist, in which: i) the second individual doses are administered less frequently than the first individual doses, ii) the first three individual doses and the six second individual doses are administered over a period two years or less, and iii) the VEGF antagonist is an anti-VEGF antibody, a VEGF receptor or derivative thereof that binds to VEGF or VEGF-Trap. |
| priorityDate | 2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 481.